Swappie co-founder’s AI HealthTech startup Treat raises €3 million to streamline private healthcare
Treat, a Helsinki-based HealthTech startup, has raised €3 million in a pre-Seed round led by byFounders, an early backer of Lovable, with participation from Illusian, the investment vehicle of Supercell founder Ilkka Paananen. The company was founded in 2026 by Sami Marttinen, former CEO of Finnish recommerce company Swappie and its co-founder, together with medical doctor Antti Mauno and FinTech engineering lead Onni Wahlberg.
Treat is building an AI-native platform that connects patients with fully briefed doctors in minutes. Patients describe their symptoms in their own words in a chat interface, and an AI intake tool turns that into a structured brief. A licensed physician registered with the Finnish Supervisory Agency then reviews the case, makes every clinical decision, and either resolves it or routes the patient to appropriate follow-up care. Treat says its AI does not diagnose, assess urgency or make automated decisions, and that patient data stays within the European Economic Area and is never used to train AI models.
The service is available directly to consumers at €72 per consultation, but the company focuses mainly on employers. It is offered as a workplace health benefit that complements occupational healthcare and private insurance rather than replacing them. Employers get a tool meant to cut unnecessary sick-day costs without access to individual health data.
The business model differs from traditional private care. Treat earns revenue only when a patient's concern is resolved, and makes nothing from lab tests, clinic visits or referrals. Marttinen says he was motivated by his wife's nine repeat private-care visits before a diagnosis, which he attributes to an economic model that rewards repeat visits. According to the company, 62% of cases are resolved without a further appointment, and the median time to a doctor's review is 2 minutes and 14 seconds during service hours. More than 108,000 doctor-reviewed chat visits have been completed.
The new funding will go toward commercial expansion and product development as Treat scales its employer offering across Finland and beyond.